
    
      The trial is designed to demonstrate that the V-LAPâ„¢ implant can be positioned in the
      interatrial septum, and that Sensor pressure measurements correlate to standardized methods
      of intra-cardiac pressure measurements post-sensor implant and at the 3 month follow up
      visit. Safety will be monitored by the occurrence of adverse events throughout the trial.
    
  